Engineered AAVs for efficient noninvasive gene delivery to the central and peripheral nervous systems by Chan, Ken Y. et al.
1nature neuroscience  |  reporting checklist
February 2017
Corresponding Author: Viviana Gradinaru
Manuscript Number: NN-T58480A  
Manuscript Type: Technical Report
# Main Figures: 5
# Supplementary Figures: 8
# Supplementary Tables: 3
# Supplementary Videos: 1
Reporting Checklist for Nature Neuroscience
This checklist is used to ensure good reporting standards and to improve the reproducibility of published results. For more information, please  
read Reporting Life Sciences Research. 
 
Please note that in the event of publication, it is mandatory that authors include all relevant methodological and statistical information in the 
manuscript. 
` Statistics reporting, by figure
z  Please specify the following information for each panel reporting quantitative data, and where each item is reported (section, e.g. Results, & 
paragraph number). 

zEach figure legend should ideally contain an exact sample size (n) for each experimental group/condition, where n is an exact number and not a  
   range, a clear definition of how n is defined (for example x cells from x slices from x animals from x litters, collected over x days), a description of  
   the statistical test used, the results of the tests, any descriptive statistics and clearly defined error bars if applicable.  

z  For any experiments using custom statistics, please indicate the test used and stats obtained for each experiment.

z  Each figure legend should include a statement of how many times the experiment shown was replicated in the lab; the details of sample 
   collection should be sufficiently clear so that the replicability of the experiment is obvious to the reader. 

z  For experiments reported in the text but not in the figures, please use the paragraph number instead of the figure number.
 
Note: Mean and standard deviation are not appropriate on small samples, and plotting independent data points is usually more informative.  
When technical replicates are reported, error and significance measures reflect the experimental variability and not the variability of the biological 
process; it is misleading not to state this clearly.  
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` Representative figures
1.    Are any representative images shown (including Western blots and 
immunohistochemistry/staining) in the paper?  
If so, what figure(s)?
Figure 1c-g 
Figure 2a-c 
Figure 3a,d 
Figure 5b,e 
Supplemental Figure 3a,b 
Supplemental Figure 4a-c
2.    For each representative image, is there a clear statement of               
how many times this experiment was successfully repeated and a 
discussion of any limitations in repeatability?  
If so, where is this reported (section, paragraph #)?
Figure 1c-g - (n = 4 individual animals per group), Line 825-826 
Figure 2a-c (n = 4 individual animals per group), Lines 827-828 
Figure 3a (n = 3 individual animals per group), Lines 827-828 and 
line 400 
Figure 3d (n = 2 animals sections per section of intestine/colon) 
Lines 400-401 
Supplemental Figure 3a,b, NR 
Supplemental Figure 4a-c NR
` Statistics and general methods
1.    Is there a justification of the sample size? 
If so, how was it justified?  
Where (section, paragraph #)?  
       Even if no sample size calculation was performed, authors should 
report why the sample size is adequate to measure their effect size. 
Not done formally, Sample sizes were chosen based on preliminary 
data and suggested a large effect size. Lines 821-823
2.   Are statistical tests justified as appropriate for every figure?  
Where (section, paragraph #)?
Each figure legend outlines the statistics test used and n number. In 
addition, statistic section 820-837
a.    If there is a section summarizing the statistical methods in 
the methods, is the statistical test for each experiment 
clearly defined? 
Yes, Lines  795-812
b.   Do the data meet the assumptions of the specific statistical 
test you chose (e.g. normality for a parametric test)?  
Where is this described (section, paragraph #)?
parametric for all statistics outlined in figure legends as listed above 
in the statistical figure reporting. Line 832
c.    Is there any estimate of variance within each group of  data?  
Is the variance similar between groups that are being 
statistically compared?  
Where is this described (section, paragraph #)?
Data were not tested for normal distribution due to small sample 
sizes.
d.    Are tests specified as one- or two-sided? Yes, Fig2 and 3 statistics were all two-sided, specified in the figure 
legends
e.    Are there adjustments for multiple comparisons?  No multiple comparisons were made
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3.    To promote transparency, Nature Neuroscience has stopped allowing 
bar graphs to report statistics in the papers it publishes. If you have 
bar graphs in your paper, please make sure to switch them to dot-
plots (with central and dispersion statistics displayed) or to box-and-
whisker plots to show data distributions.
4.    Are criteria for excluding data points reported?  
Was this criterion established prior to data collection?  
Where is this described (section, paragraph #)? 
 
Yes, 798-800
5.    Define the method of randomization used to assign subjects (or 
samples) to the experimental groups and to collect and process data.   
If no randomization was used, state so.  
Where does this appear (section, paragraph #)?
Mice were randomly assigned to groups of predetermined sample 
size. All experiments with direct comparisons were performed in 
parallel to minimize variability. Lines 632-633. 
To minimize bias, when direct comparisons for quantification  Lines 
762-765
6.    Is a statement of the extent to which investigator knew the group 
allocation during the experiment and in assessing outcome included?   
If no blinding was done, state so.  
Where (section, paragraph #)?
Manual cell counting in the striatum and cortex was performed by a 
blinded observer (Fig. 2e).  Automated counting was performed of 
Purkinje cells in the cerebellum (Fig. 2e). Lines 765-767.
7.    For experiments in live vertebrates, is a statement of compliance with 
ethical guidelines/regulations included?  
Where (section, paragraph #)?
Yes, methods, lines 628-632.
8.    Is the species of the animals used reported?  
Where (section, paragraph #)?
Yes, methods, lines 629-631
9.    Is the strain of the animals (including background strains of KO/
transgenic animals used) reported?  
Where (section, paragraph #)?
Yes, methods, lines 629-631
10.    Is the sex of the animals/subjects used reported?  
Where (section, paragraph #)?
Yes, methods, line 631-632
11.  Is the age of the animals/subjects reported?  
Where (section, paragraph #)?
Yes, line 640
12.  For animals housed in a vivarium, is the light/dark cycle reported? 
Where (section, paragraph #)?
No
13.  For animals housed in a vivarium, is the housing group (i.e. number of 
animals per cage) reported? 
Where (section, paragraph #)?
No
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14.  For behavioral experiments, is the time of day reported (e.g. light or 
dark cycle)?  
Where (section, paragraph #)?
No
15.  Is the previous history of the animals/subjects (e.g. prior drug 
administration, surgery, behavioral testing) reported? 
Where (section, paragraph #)? 
 
No
a.    If multiple behavioral tests were conducted in the same 
group of animals, is this reported? 
Where (section, paragraph #)?
No
16.  If any animals/subjects were excluded from analysis, is this reported?  
Where (section, paragraph #)?
1 animal in each group did not show any virus transduction in figure 
2 and were excluded. Line 823-825
a.    How were the criteria for exclusion defined?  
Where is this described (section, paragraph #)?
complete lack of expression. Line 823-825
b.    Specify reasons for any discrepancy between the number of 
animals at the beginning and end of the study.   
Where is this described (section, paragraph #)?
complete lack of expression was observed, possible reason was due 
to failed retro orbital injection during virus injection. Line 823-825
` Reagents
1.    Have antibodies been validated for use in the system under study 
(assay and species)? 
All antibodies used within the study are reported in methods 
section lines 696-751
a.    Is antibody catalog number given?  
Where does this appear (section, paragraph #)?
Yes. 696-751
b.    Where were the validation data reported (citation, 
supplementary information, Antibodypedia)?  
Where does this appear (section, paragraph #)?
NA
2.    Cell line identity 
                 a.     Are any cell lines used in this paper listed in the database of    
                         commonly misidentified cell lines maintained by ICLAC and  
                         NCBI Biosample?  
                  Where (section, paragraph #)?
No
b.    If yes, include in the Methods section a scientific 
justification of their use--indicate here in which section and 
paragraph the justification can be found.
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c.    For each cell line, include in the Methods section a 
statement that specifies: 
        - the source of the cell lines 
        - have the cell lines been authenticated? If so, by which   
          method? 
        - have the cell lines been tested for mycoplasma  
          contamination? 
Where (section, paragraph #)?
Virus production , line 682
` Data availability
Provide a Data availability statement in the Methods section under "Data 
availability", which should include, where applicable: 
• Accession codes for deposited data 
• Other unique identifiers (such as DOIs and hyperlinks for any other 
datasets) 
• At a minimum, a statement confirming that all relevant data are 
available from the authors 
• Formal citations of datasets that are assigned DOIs 
• A statement regarding data available in the manuscript as source 
data 
• A statement regarding data available with restrictions 
    
See our data availability and data citations policy page for more 
information. 
   
Data deposition in a public repository is mandatory for: 
     a. Protein, DNA and RNA sequences 
     b. Macromolecular structures 
     c. Crystallographic data for small molecules 
     d. Microarray data 
Deposition is strongly recommended for many other datasets for which 
structured public repositories exist; more details on our data policy 
are available here. We encourage the provision of other source data 
in supplementary information or in unstructured repositories such as 
Figshare and Dryad. 
We encourage publication of Data Descriptors (see Scientific Data) to 
maximize data reuse.  
 Where is the Data Availability statement provided (section, paragraph 
#)? 
At the stage of publication, novel capsid sequences, will be 
deposited to Genbank and all viral plasmids will be deposited to 
addgene.com
` Computer code/software
Any custom algorithm/software that is central to the methods must be supplied by the authors in a usable and readable form for readers at the 
time of publication. However, referees may ask for this information at any time during the review process.
 1.   Identify all custom software or scripts that were required to conduct 
the study and where in the procedures each was used.
custom Matlab and Python scripts were used to assist in data 
analysis
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2.   If computer code was used to generate results that are central to the 
paper's conclusions, include a statement in the Methods section 
under "Code availability" to indicate whether and how the code can 
be accessed. Include version information as necessary and any 
restrictions on availability.
Code will be deposited to github near publication.
` Human subjects
1.    Which IRB approved the protocol?  
Where is this stated (section, paragraph #)?
NA
2.    Is demographic information on all subjects provided?  
Where (section, paragraph #)?
3.    Is the number of human subjects, their age and sex clearly defined?  
Where (section, paragraph #)?
4.    Are the inclusion and exclusion criteria (if any) clearly specified?  
Where (section, paragraph #)? 
5.    How well were the groups matched?  
Where is this information described (section, paragraph #)?
6.    Is a statement included confirming that informed consent was 
obtained from all subjects? 
Where (section, paragraph #)?
7.    For publication of patient photos, is a statement included confirming 
that consent to publish was obtained? 
Where (section, paragraph #)?
` Additional comments
     Additional Comments
Nature Neuroscience: doi:10.1038/nn.4593
